Skip to content
Open access

Deep Immunophenotyping Reveals Distinct Immune Signatures in Axial Spondyloarthritis and Psoriatic Arthritis.

Jul 2026 · Arthritis & Rheumatology · 0 citations
Medicine

TL;DR

AxSpA shows enrichment of innate-associated and broadly activated immune features, whereas PsA is characterized by adaptive and memory-associated immune responses, which may support biomarker-guided stratification within the SpA spectrum.

Abstract

Objective

Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are overlapping yet distinct conditions within the spondyloarthritis (SpA) spectrum. As divergent immunophenotypes may influence disease course and therapeutic response, we compared immune cell subsets, cytokine profiles, and inflammatory mediators.

Methods

Peripheral blood mononuclear cells (PBMCs) from 179 patients (88 axSpA, 91 PsA) and 49 healthy donors were profiled using spectral flow cytometry, comprising 230 million acquired events and 55 million quality-controlled cells. Immune subsets, activation- and differentiation-associated markers and cytokines were analyzed to define disease-specific profiles.

Results

AxSpA and PsA exhibited distinct immunophenotypic profiles. AxSpA was characterized by expansion of double-negative and γδ T cells, increased plasmablasts and CD21low B cells, and higher expression of activation-associated markers (CD80, CD86, CD95), consistent with dysregulated innate-like immune activation. PsA showed increased dendritic cells and a higher frequency of IgM+IgD- memory B cells. Both diseases exhibited Th1 enrichment; however, axSpA showed additional Th17 skewing and increased expression of activation- and checkpoint-associated markers (HLA-DR, CD38, PD-1), whereas PsA displayed more central memory CD4+ T cells and lower PD-1 expression. Cytokine profiling revealed elevated inflammasome-related and innate cytokines in axSpA, while PsA showed increased sIL2R, IL-17A, sTNFR1, and vascular-associated inflammatory mediators. Regularized regression identified a stable immune signature distinguishing axSpA from PsA (cross-validated AUC 0.94).

Conclusion

AxSpA and PsA share overlapping yet distinguishable immunophenotypic signatures. AxSpA shows enrichment of innate-associated and broadly activated immune features, whereas PsA is characterized by adaptive and memory-associated immune responses. These findings may support biomarker-guided stratification within the SpA spectrum.

Read PDF

Similar papers

Open access Jul 2026

Integrated peripheral immune profiling reveals B-cell dysregulation and CD8 effector signatures in chronic inflammatory demyelinating polyneuropathy

Integrated peripheral immune profiling identified candidate CIDP-associated immune signatures including dysregulated B-cell activation despite numerical reduction and a prominent cytotoxic CD8 T-cell program within a type I interferon– and inflammasome-skewed inflammatory milieu.

Hyunjin Kim, Jinhui Chun, D. Cha et al. · 0 citations
Open access Aug 2026

Cross-disease immunological comparison reveals shared systemic immune activation across the broader spondyloarthritis spectrum.

To perform cross-disease immunological comparison across the broader spondyloarthritis (SpA) spectrum and examine their association with disease activity. We analyzed 111 patients with active broader SpA spectrum (ankylosing spondylitis, inflammatory bowel disease-associated SpA, psoriatic arthritis, pustulotic arthro-...

Koichi Saito, M. Akiyama, K. Shimanuki et al. · 0 citations
#protein folding Aug 2026

The Integrin Signature of Ankylosing Spondylitis: Divergent Regulation of CD29 and CD49b in HLA-B27-Positive Cohorts in Iraqi Patients

A divergent regulation of CD29 and CD49b integrins associated with HLA-B27 status in Iraqi AS patients is suggested and longitudinal validation is required to confirm their clinical utility as diagnostic or therapeutic targets.

Ahmed Ali Alshammari, M. Mohsin · 0 citations
Aug 2026

STK17B/DRAK2 in Axial Spondyloarthritis: Expression Patterns in Blood and Tissue

Pre-biologic STK17B expression was higher among patients who were later identified as non-responders to IL-17i compared with responders, suggesting that DRAK2 upregulation contributes to axSpA-related inflammation and to treatment resistance, warranting further mechanistic investigation.

P. Remalante-Rayco, S. Jo, Addison Pacheco et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.